MedTrace Logo

CARdioprotection in Myocardial Infarction

NCT02967965 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2024-02-29

No results posted yet for this study

Summary

CARIM is a prospective cohort of 2,000 patients with a first myocardial infarction and undergoing reperfusion therapy. Therefore, male and female patients older than 18 years and younger than 90 years with onset of chest pain of less than 12 hours who need a primary percutaneous coronary intervention (PCI) for a ST elevation segment MI (STEMI) will be recruited.

Conditions

  • Myocardial Infarct

Interventions

OTHER

Imagery

MRI at year 3

Sponsors & Collaborators

  • EZUS-LYON 1

    lead OTHER

Principal Investigators

  • Genevieve DERUMEAUX, Professor · APHP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2022-12-31
Completion
2024-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02967965 on ClinicalTrials.gov